Topical non-steroidal anti-inflammatory drugs vs musculoskeletal pain: the focus of the topical patch Menovazan PRO

Mozhyna T.L.

Головна
Публікації
Topical non-steroidal anti-inflammatory drugs vs musculoskeletal pain: the focus of the topical patch Menovazan PRO

29 лютого 2024

558

Orthopedics and Traumatology

Mozhyna T.L.

УДК: 616.74+616.72

DOI: 10.32471/umj.1680-3051.159.251597

Ключові слова :

Menovazan PRO,

non-steroidal anti-inflammatory drugs,

patch,

topical application

Спеціальності :

Orthopedics and Traumatology

Резюме

Current World Health Organization guidelines and international, American, European and Chinese guidelines recommend the use of topical non-steroidal anti-inflammatory drugs as first-line treatment for musculoskeletal pain due to their comparable efficacy to oral non-steroidal anti-inflammatory drugs and better safety than the latter. The topical patch Menovazan PRO, which contains menthol, meloxicam, procaine and benzocaine, has analgesic, anti-inflammatory and cooling effects. Menovazan PRO is recommended for the mild/moderate musculoskeletal pain of traumatic, inflammatory and dystrophic genesis; it can be used in patients with comorbid gastrointestinal and cardiovascular pathology.

References

1. McMahon S.B., Dargan P., Lanas A. et al. (2021) The burden of musculoskeletal pain and the role of topical non-steroidal anti-inflammatory drugs (NSAIDs) in its treatment. Ten underpinning statements from a global pain faculty. Curr. Med. Res. Opin., 37(2): 287–292.
2. http://www.who.int/news-room/fact-sheets/detail/musculoskeletal-conditions.
3. Anekar A.A., Hendrix J.M., Cascella M. (2024) WHO Analgesic Ladder. Treasure Island.
4. Qaseem A., McLean R.M., O’Gurek D. et al. (2020) Nonpharmacologic and Pharmacologic Management of Acute Pain From Non-Low Back, Musculoskeletal Injuries in Adults: A Clinical Guideline From the American College of Physicians and American Academy of Family Physicians. Ann. Intern. Med., 173(9): 739–748.
5. Shi C., Ye Z., Shao Z. et al. (2023) Multidisciplinary Guidelines for the Rational Use of Topical Non-Steroidal Anti-Inflammatory Drugs for Musculoskeletal Pain. J. Clin. Med.,12: 1544.
6. Kloppenburg M., Kroon F.P., Blanco F. et al. (2019) 2018 update of the EULAR recommendations for the management of hand osteoarthritis. Ann. Rheum. Dis., 78(1): 16–24.
7. Hunt R., Lazebnik L., Marakhouski Y. et al. (2018) International Consensus on Guiding Recommendations for Management of Patients with Nonsteroidal Antiinflammatory Drugs Induced Gastropathy-ICON-G. Euroasian J. Hepatogastroenterol., 8(2): 148–160.
8. Mohammadi-Samani S., Yousefi G., Mohammadi F. et al. (2014) Meloxicam transdermal delivery: effect of eutectic point on the rate and extent of skin permeation. Iran J. Basic Med. Sci., 17(2): 112–118.
9. Leppert W., Malec-Milewska M., Zajaczkowska R. et al. (2018) Transdermal and Topical Drug Administration in the Treatment of Pain. Molecules, 23(3): 681.
10. compendium.com.ua/med/563153/867413.
11. Chen J., Gao Y. (2016) Strategies for meloxicam delivery to and across the skin: a review. Drug Deliv., 23(8): 3146–3156. doi: 10.3109/10717544.2016.1157839.
12. Drakalska Sersemova Е. (2022) Evaluation of topical preparations of meloxicam — a review. Knowledge, 4: 749–754.
13. Yuan Y., Chen X.Y., Li S. et al. (2009) Pharmacokinetic studies of meloxicam following oral and transdermal administration in Beagle dogs. Acta Pharmacol. Sin., 30(7): 1060–1064.
14. Jyothi V., Veerabomma H., Tryphena K. et al. (2023) Acute and sub-acute dermal toxicity of meloxicam emulgel: Analysis of biochemical, hematological, histopathological and immunohistochemical expression. Biochem. Biophys. Res. Commun., 660: 88–95. doi: 10.1016/j.bbrc.2023.04.001.
15. Zhang Z.J., Osmałek T., Michniak-Kohn B. (2020) Deformable Liposomal Hydrogel for Dermal and Transdermal Delivery of Meloxicam. Int. J. Nanomedicine, 15: 9319–9335. doi: 10.2147/IJN.S274954.
16. Li Z., Zhang H., Wang Y. et al. (2022) The distinctive role of menthol in pain and analgesia: Mechanisms, practices, and advances. Front Mol. Neurosci., 15: 1006908.
17. Wang G., Hurr C. (2023) Effects of cutaneous administration of an over-the-counter menthol cream during temperate-water immersion for exercise-induced hyperthermia in men. Front. Physiol., 14: 1161240. doi: 10.3389/fphys.2023.1161240.
18. Whalen A., Farrell K., Roberts S. et al. (2019) Topical Analgesic Improved or Maintained Ballistic Hip Flexion Range of Motion with Treated and Untreated Legs. J. Sports Sci. Med., 18(3): 552–558.
19. Üstündağ Okur N., Çağlar E.Ş., Arpa M. et al. (2017) Preparation and evaluation of novel microemulsion-based hydrogels for dermal delivery of benzocaine. Pharm. Dev. Technol., 22(4): 500–510. doi: 10.3109/10837450.2015.1131716.
20. Eslamian L., Borzabadi-Farahani A., Edini H. (2013) The analgesic effect of benzocaine mucoadhesive patches on orthodontic pain caused by elastomeric separators, a preliminary study. Acta Odontol. Scand., 71(5): 1168–1173.
21. Mei F., Li J., Zhang L. et al. (2022) Preference of Orthopedic Practitioners Toward the Use of Topical Medicine for Musculoskeletal Pain Management in China: A National Survey. Orthop. Surg., 14(10): 2470–2479. doi: 10.1111/os.13446.
22. Takeda O., Chiba D., Ishibashi Y. et al. (2017) Patient-Physician Differences in Desired Characteristics of NSAID Plasters: An Online Survey. Pain Res. Manag., 2017: 5787854.